As concerns mount regarding the health of the private credit ecosystem, Oaktree Capital Management co-chairman Howard Marks offers perspective–and some investing advice–when it comes to private lending. Former FDA Commissioner Dr. Scott Gottlieb discusses Eli Lilly’s deal to expand its cancer treatment pipeline as well as President Trump’s executive order on therapeutic psychedelics. Plus, Kevin Warsh’s Fed Chair nomination hearing is this week, and Anthropic’s Mythos is at work within the NSA, despite being blacklisted by the US government. 

Steve Liesman          
Howard Marks             
Dr. Scott Gottlieb          

In this episode:
Steve Liesman, @steveliesman
Andrew Ross Sorkin, @andrewrsorkin
Becky Quick, @BeckyQuick
Joe Kernen, @JoeSquawk
Katie Kramer, @Kramer_Katie

President Trump: We’re Going to End Up with A Great Deal 4/21/26

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.